Snowball logo
logo
0038

Boryung Pharm

003850 β€’ KO
β‚©8,330.00+β‚©30.00Β  (0.36%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
627,279.4760,475.8859,625.61,017,106.71,017,427.41,060,335.5
COGS
362,342453,288.7506,195.7653,749.8645,145672,939.6
Gross Profit
264,937.4307,187.2353,429.9363,356.9372,282.4387,395.9
Operating Expenses & Income
Operating Income
41,448.256,602.968,26770,472.265,066.772,737.2
Total Operating Expenses
585,831.2703,873791,358.6946,634.4952,360.6987,598.3
R&D Expenses
39,14641,705.147,286.151,469.365,089.261,867.6
Selling General & Admin Expenses
89,459.692,017.492,05799,076.799,581.6101,499.6
Earnings from Continuing Operations
Interest Expense
(4,478.1)(6,127.4)(9,549.1)(8,997.7)(11,575.4)(13,237.8)
Interest Income
1,398.54,524.2871.85,965.98,558.912,396.6
Income Tax Expense
27,598.916,933.7----
Net Income
Net Income
43,044.341,894.440,202.869,633.364,302.9120,582.7
Supplemental
EBIT
41,448.256,602.965,854.771,95781,424.8160,943
EBITDA
107,270.4102,643.6110,241.8114,806.2124,946.7208,332.7
In millions of KRW, except % and values per 1 share